TX-1877: Design, synthesis, and biological activities as a BRM- functional hypoxic cell radiosensitizer

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 4, 1998, Pages 799-802

  Kasai, Soko ^a   Nagasawa, Hideko ^a   Kuwasaka, Hideki ^a   Oshodani, Tomoko ^a   Nishioka, Akihito ^b   Ogawa, Yasuhiro ^b   Yoshida, Shoji ^b   Inayama, Seiichi ^c,d   Inomata, Taisuke ^b   Hori, Hitoshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c Inst of Oriental Medical Science   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

Antimetastasis; Biological response modifier; Hypoxic cell radiosensitizer; TX 1877

Indexed keywords

2 NITROIMIDAZOLE ACETAMIDE; 2 NITROIMIDAZOLE DERIVATIVE; BIOLOGICAL RESPONSE MODIFIER; KIN 806; KIN 806 PLUS R; MISONIDAZOLE; RADIOSENSITIZING AGENT; TX 1877; TX 1877 PLUS R; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; CELL INFILTRATION; CONFERENCE PAPER; CONTROLLED STUDY; GROWTH INHIBITION; IMMUNOPOTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG METASTASIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RADIOSENSITIVITY;

ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; CELL HYPOXIA; DRUG DESIGN; FEMALE; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; NITROIMIDAZOLES; RADIATION-SENSITIZING AGENTS;

EID: 0031773926     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00328-9     Document Type: Conference Paper

References (15)

1. Coleman C.N., Bump E.A., Kramer R.A. Chemical modifiers of cancer treatment. J Clin Oncol. 6:1988;709-733.
2. Lee D.J., Pajak T.F., Stetz J., Order S.E., Weissberg J.B., Fischer J.J. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck a RTOG randomized study (#79-04) . Int J Radiat Oncol Biol Phys. 16:1989;465-470.
3. Hori H., Jin C.-Z., Kiyono M., Kasai S., Shimamura M., Inayama S. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles. Bioorg Med Chem. 5:1997;591-599.
4. Hori H., Murayama C., Mori T., Shibamoto Y., Abe M., Onoyama Y., Inayama S. KIH-802 2-Nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer . Int J Radiat Oncol Biol Phys. 16:1989;1029-1032.
5. Nagasawa H., Bando M., Hori H., Satoh T., Tada T., Onoyama Y., Inayama S. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers. Int J Radiat Oncol Biol Phys. 22:1992;561-564.
6. Hamada N., Inomata T., Terashima M., Ogawa Y., Yoshida S., Nagasawa H., Hori H., Inayama S. Anti-tumor effect of radiosensitizer KIN-806. Biotherapy. 8:1994;489-490.
7. Nagasawa H. Studies on tumor specific treatment targetting hypoxic cell via radiosensitization and chemical modification. In: Shibata S., eds. Advance in pharmaceutical sciences. Vol. 10. Tokyo, Japan: Res. Fund. Pharm. Sci.; 1994. p. 147-159.
8. Inomata T., Itoh S., Mesaki K., Tsuboi N., Nishioka A., Ogawa Y., Yoshida S., Hori H., Inayama S. An experimental study of the inhibition of bifunctional hypoxic cell radiosensitizer KIH-896 on lung metastasis. Nippon Acta Radiol. 57:1996;S212.
9. Fujita T., Iwasa J., Hansch C. A new substituent constant, π, derived form partition coefficients. J Am Chem Soc. 86:1964;5175-5180.
10. Shibamoto Y., Ono K., Takahashi H., Kano E., Hori H., Shibata T., Inayama S., Abe M. An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells. Jpn J Cancer Res (Gann). 77:1986;1027-1033.
11. Inayama S., Hori H., Ohsaka T., Mori T., Shibata C. An approach to the design and synthesis of mercaptoimidazole derivatives containing oxidized sulfur based on electron affinity sensitization. Gann (Jpn J Cancer Res). 72:1981;156-159.
12. Adams G.E., Flockhart I.R., Smithen C.E., Stratford I.J., Wardman P., Watts M.E. Electron affinic sensitization VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers . Radiat Res. 67:1976;9-20.
13. Kanclerz A., Chapman J.D. Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice. Int J Radiat Oncol Biol Phys. 14:1988;309-316.
14. Inomata T. Kochi group. Unpublished work.
15. Bowen D., Southerland W.M., Bowen C.D., Hughes D.E. Interaction of swainsonine with lymphoid and highly perfused tissues a pharmacokinetics explanation for sustained immunomodulation . Anticancer Res. 17:1997;4345-4346.